<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab4">
 <label>Table 4</label>
 <caption>
  <p>Objective response rate by IEAC assessment</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Response, 
     <italic>n</italic> (%)
    </th>
    <th>Phase 2 (
     <italic>n</italic> = 41)
    </th>
    <th>Phase 1 + 2 (
     <italic>n</italic> = 45)
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td colspan="3">Primary analysis</td>
   </tr>
   <tr>
    <td> DCR (CR + PR+ SD)</td>
    <td>16 (39)</td>
    <td>17 (38)</td>
   </tr>
   <tr>
    <td> ORR (CR + PR) 90% CI</td>
    <td>9 (22)
     <sup>a</sup>
     <break/>12–35
    </td>
    <td>10 (22)
     <break/>13–35
    </td>
   </tr>
   <tr>
    <td> CR</td>
    <td>4 (10)</td>
    <td>4 (9)</td>
   </tr>
   <tr>
    <td> PR</td>
    <td>5 (12)</td>
    <td>6 (13)</td>
   </tr>
   <tr>
    <td> SD</td>
    <td>7 (17)</td>
    <td>7 (16)</td>
   </tr>
   <tr>
    <td> PD/RD</td>
    <td>24 (59)</td>
    <td>26 (58)</td>
   </tr>
   <tr>
    <td> Not evaluable</td>
    <td>1 (2)</td>
    <td>2 (4)</td>
   </tr>
   <tr>
    <td colspan="3">Final analysis</td>
   </tr>
   <tr>
    <td> DCR (CR + PR+ SD)</td>
    <td>16 (39)</td>
    <td>17 (38)</td>
   </tr>
   <tr>
    <td> ORR (CR + PR) 90% CI</td>
    <td>10 (25)
     <sup>a</sup>
     <break/>14–38
    </td>
    <td>11 (24)
     <break/>14–37
    </td>
   </tr>
   <tr>
    <td> CR</td>
    <td>4 (10)</td>
    <td>4 (9)</td>
   </tr>
   <tr>
    <td> PR</td>
    <td>6 (15)</td>
    <td>7 (16)</td>
   </tr>
   <tr>
    <td> SD</td>
    <td>6 (15)</td>
    <td>6 (13)</td>
   </tr>
   <tr>
    <td> PD/RD</td>
    <td>24 (59)</td>
    <td>26 (58)</td>
   </tr>
   <tr>
    <td> Not evaluable</td>
    <td>1 (2)</td>
    <td>2 (4)</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>
   <italic>CR</italic> complete response, 
   <italic>DCR</italic> disease control rate, 
   <italic>IEAC</italic> Independent Efficacy Assessment Committee, 
   <italic>ORR</italic> objective response rate, 
   <italic>PD</italic> progressive disease, 
   <italic>PR</italic> partial response, 
   <italic>RD</italic> relapsed disease, 
   <italic>SD</italic> stable disease
  </p>
  <p>
   <sup>a</sup>Uniformly minimum variance unbiased estimator (UMVUE)
  </p>
 </table-wrap-foot>
</table-wrap>
